Impact of lymphadenectomy and lymphoedema on health-related quality of life 1 year after surgery for endometrial cancer. A prospective longitudinal multicentre study

BJOG. 2022 Feb;129(3):450-460. doi: 10.1111/1471-0528.16870. Epub 2021 Sep 7.

Abstract

Objective: To assess the impact of lymphadenectomy and lymphoedema of the lower limbs (LLL) on health-related quality of life (HRQoL) 1 year after surgery for endometrial cancer (EC).

Design: Prospective longitudinal cohort multicentre study.

Setting: Departments of obstetrics and gynaecology at four university hospitals, six central hospitals and four county hospitals in Sweden.

Population: Two-hundred-and-thirty-five women with early stage EC were included; 116 with high-risk EC underwent surgery including lymphadenectomy (+LA), and 119 with low-risk EC had surgery without lymphadenectomy (-LA).

Methods: The generic SF-36 and EQ-5D-3L and the lymphoedema-specific LYMQOL questionnaire were used to assess HRQoL. LLL was assessed by systematic circumferential measurements of the legs enabling volume estimation, clinical evaluation and patient-reported perception of leg swelling. All assessments were carried out on four occasions; preoperatively, and 4-6 weeks, 6 months and 1 year postoperatively.

Main outcome measure: HRQoL scores.

Results: No significant differences were seen in HRQoL between the +LA and -LA groups 1 year postoperatively. Irrespective of method of determining LLL, women with LLL were significantly more affected in the LYMQOL domains Function, Appearance/body image and Physical symptoms, but not in the domain Emotion/mood, than women without LLL. No such differences were seen in the generic HRQoL or in the LYMQOL global score between the groups with and without LLL.

Conclusions: Lymphadenectomy did not seem to affect generic HRQoL adversely. Irrespective of the method of measuring, LLL affected the lymphoedema-specific HRQoL negatively, mainly in physical domains, but had no impact on the generic HRQoL.

Tweetable abstract: Lymphoedema has impact on lymphoedema-specific, but not on generic, HRQoL, 1 year after surgery for EC.

Keywords: Endometrial cancer; health-related quality-of-life; lower limb; lymphadenectomy; lymphoedema.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Cost of Illness
  • Endometrial Neoplasms / surgery*
  • Female
  • Humans
  • Longitudinal Studies
  • Lymph Node Excision*
  • Lymphedema / epidemiology*
  • Lymphedema / etiology
  • Middle Aged
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / etiology
  • Postoperative Period
  • Prospective Studies
  • Quality of Life*
  • Surveys and Questionnaires
  • Sweden
  • Treatment Outcome